{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-23-000003","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.566306+00:00","generated_at":"2026-06-20T17:23:31.091010+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integra pre-announces Q4 rev ~$397-398M, adj EPS above guidance; FY rev ~$1,557-1,558M","bullets":["Q4 2022 revenue expected $397M-$398M, down ~2% reported, up ~3% organic vs Q4 2021.","Adjusted EPS expected above high end of October guidance range.","FY2022 revenue expected $1,557M-$1,558M, up ~1% reported, +4% organic.","Full-year adjusted EPS above high end of October guidance and above midpoint of original Feb guidance.","Company presenting at JP Morgan Healthcare Conference on Jan 11, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-23-000003","json":"https://secwatch.observer/filing/0000917520-23-000003.json","markdown":"https://secwatch.observer/filing/0000917520-23-000003.md","text":"https://secwatch.observer/filing/0000917520-23-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/0000917520-23-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/iart-20230110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:23:31.091010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f16f3f4dc01e17d1fbbd1ced2b20cd8095e3de86","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP updated its fourth quarter and full-year 2022 guidance (reaffirmed).","evidence_excerpt":"On January 10, 2023, Integra LifeSciences Holdings Corporation (the \"Company\") issued a press release announcing certain unaudited, preliminary fourth quarter and full-year 2022 financial results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/0000917520-23-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full-year 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}